The vitamin D binding protein DBP

Vitamin D

Volumn , Issue , 2011, Pages 57-72

  Bouillon, Roger ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84862495419     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-381978-9.10005-8     Document Type: Chapter

References (148)

1. Hirschfeld J. Immune-electrophoretic demonstration of qualitative differences in human sera and their relation to the haptoglobins. Acta Pathol. Microbiol. Scand 1959, 47:160-168.
2. Cleve H., Constans J. The mutants of the vitamin-D-binding protein - more than 120 variants of the GC/DBP system. Vox. Sanguinis 1988, 54:215-225.
3. Westwood S.A., Werrett D.J. Group-specific component - a review of the isoelectric-focusing methods and auxiliary methods available for the separation of its phenotypes. Forensic Sci. Int 1986, 32:135-150.
4. Daiger S.P., Schanfield M.S., Cavallisforza L.L. Group-specific component (GC) proteins bind vitamin-D and 25-hydroxyvitamin-D. Proc. Natl. Acad. Sci. USA 1975, 72:2076-2080.
5. Bouillon R., Vanbaelen H., Rombauts W., Demoor P. Purification and characterization of human-serum binding-protein for 25-hydroxycholecalciferol (transcalciferin) - identity with group-specific component. Eur. J. Biochem 1976, 66:285-291.
6. Haddad J.G., Walgate J. 25-Hydroxyvitamin D transport in human-plasma - isolation and partial characterization of calcifidiol-binding protein. J. Biol. Chem 1976, 251:4803-4809.
7. Safadi F.F., Thornton P., Magiera H., Hollis B.W., Gentile M., Haddad J.G., et al. Osteopathy and resistance to vitamin D toxicity in mice null for vitamin D binding protein. J. Clin. Invest 1999, 103:239-251.
8. Verboven C., Ragijns A., De Maeyer M., Van Baelen H., Bouillon R., De Ranter C. A structural basis for the unique binding features of the human vitamin D-binding protein. Nat. Struct. Biol 2002, 9:131-136.
9. Vanbaelen H., Bouillon R., Demoor P. Vitamin-D-binding protein (GC-globulin) binds actin. J. Biol. Chem 1980, 255:2270-2272.
10. Laing C.J., Cooke N. Vitamin D-binding Protein. Vitamin D 2005, 117-134. Academic Press. second ed. J.W. Pike, F.H. Glorieux, D. Feldman (Eds.).
11. Bogaerts I., Verboven C. New Aspects of DBP. Vitamin D 2005, 135-152. Academic Press. second ed. J.W. Pike, F.H. Glorieux, D. Feldman (Eds.).
12. 3. Vitamin D 2005, 153-166. Academic Press. second ed. J.W. Pike, F.H. Glorieux, D. Feldman (Eds.).
13. White P., Cooke N. The multifunctional properties and characteristics of vitamin D-binding protein. Trends Endocrin. Metab 2000, 11:320-327.
14. Cooke N.E., Willard H.F., David E.V., George D.L. Direct regional assignment of the gene for vitamin-D binding-protein (GC-globulin) to human-chromosome 4q11-q13 and identification of an associated DNA polymorphism. Human Genet 1986, 73:225-229.
15. Harper M.E., Dugaiczyk A. Linkage of the evolutionarily-related serum-albumin and alpha-fetoprotein genes within q11-22 of human chromosome-4. Am. J. Human Genet 1983, 35:565-572.
16. Cooke N.E., Levan G., Szpirer J. The rat vitamin-D binding-protein (GC-globulin) gene is syntenic with the rat albumin and alpha-fetoprotein genes on chromosome-14. Cytogenet. Cell Genet 1987, 44:98-100.
17. Yang F., Bergeron J.M., Linehan L.A., Lalley P.A., Sakaguchi A.Y., Bowman B.H. Mapping and conservation of the group-specific component gene in mouse. Genomics 1990, 7:509-516.
18. Weitkamp L.R., Allen P.Z. Evolutionary conservation of equine GC alleles and of mammalian GC-albumin linkage. Genetics 1979, 92:1347-1354.
19. Juneja R.K., Sandberg K., Andersson L., Gahne B. Close linkage between albumin and vitamin-D binding-protein (GC) loci in chicken - a 300 million year old linkage group. Genet. Res 1982, 40:95-98.
20. Lichenstein H.S., Lyons D.E., Wurfel M.M., Johnson D.A., McGinley M.D., Leidli J.C., et al. Afamin is a new member of the albumin, alpha-fetoprotein, and vitamin-D-binding protein gene family. J. Biol. Chem 1994, 269:18149-18154.
21. Belanger L., Roy S., Allard D. New albumin gene 3' adjacent to the alpha(1)-fetoprotein locus. J. Biol. Chem 1994, 269:5481-5484.
22. Gabant P., Forrester L., Nichols J., Van Reeth T., De Mees C., Pajack B., et al. Alpha-fetoprotein, the major fetal-serum protein, is not essential for embryonic development but is required for female fertility. Proc. Natl. Acad. Sci. USA 2002, 99:12865-12870.
23. E.S. Noel, M. dos Reis, Z. Arain, E.A. Ober Analysis of the Albumin/alpha-Fetoprotein/Afamin/Group specific component gene family in the context of zebrafish liver differentiation. Gene Expr. Patterns 10:237-243.
24. Osawa M., Tsuji T., Yukawa N., Saito T., Takeichi S. Cloning and sequence-analysis of cDNA-encoding rabbit vitamin-D-binding protein (GC-globulin). Biochem. Mol. Biol. Int 1994, 34:1003-1009.
25. Burnside J., Sofer L. Gallus Gallus vitamin D binding protein cDNA. GenBank direct submission accession number AF 121350 1999.
26. Hunt J.L., Licht P. Identification and structural characterization of a novel member of the vitamin D binding protein family. Comp. Biochem. Physiol. B-Biochem. Mol. Biol 1998, 121:397-406.
27. Schoentgen F., Metzboutigue M.H., Jolles J., Constans J., Jolles P. Complete amino-acid-sequence of human vitamin-D-binding protein (group-specific component) - evidence of a 3-fold internal homology as in serum-albumin and alpha-fetoprotein. Biochimica et Biophysica Acta 1986, 871:189-198.
28. Litwiller R., Fass D., Kumar R. The amino-acid-sequence of the nh2-terminal portion of rat and human vitamin-D binding-protein - evidence for a high degree of homology between rat and human vitamin-D binding-protein. Life Sci 1986, 38:2179-2184.
29. Eiferman F.A., Young P.R., Scott R.W., Tilghman S.M. Intragenic amplification and divergence in the mouse alpha-fetoprotein gene. Nature 1981, 294:713-718.
30. Gibbs P.E.M., Dugaiczyk A. Origin of structural domains of the serum-albumin gene family and a predicted structure of the gene for vitamin-D-binding protein. Mol. Biol. Evol 1987, 4:364-379.
31. Haefliger D.N., Moskaitis J.E., Schoenberg D.R., Wahli W. Amphibian albumins as members of the albumin, alpha-fetoprotein, vitamin-D-binding protein multigene family. J. Mol. Evol 1989, 29:344-354.
32. Gibbs P.E.M., Witke W.F., Dugaiczyk A. The molecular clock runs at different rates among closely related members of a gene family. J. Mol. Evol 1998, 46:552-561.
33. Head J.F., Swamy N., Ray R. Crystal structure of the complex between actin and human vitamin D-binding protein at 2.5 angstrom resolution. Biochemistry 2002, 41:9015-9020.
34. Otterbein L.R., Cosio C., Graceffa P., Dominguez R. Crystal structures of the vitamin D-binding protein and its complex with actin: structural basis of the actin-scavenger system. Proc. Natl. Acad. Sci. USA 2002, 99:8003-8008.
35. Swamy N., Head J.F., Weitz D., Ray R. Biochemical and preliminary crystallographic characterization of the vitamin D sterol- and actin-binding by human vitamin D-binding protein. Arch. Biochem. and Biophys 2002, 402:14-23.
36. Verboven C., Bogaerts I., Waelkens E., Rabijns A., Van Baelen H., Bouillon R., et al. Actin-DBP: the perfect structural fit?. Acta Crystallographica. Section D-Biological Crystallography 2003, 59:263-273.
37. He X.M., Carter D.C. Atomic-structure and chemistry of human serum-albumin. Nature 1992, 358:209-215.
38. Sugio S., Kashima A., Mochizuki S., Noda M., Kobayashi K. Crystal structure of human serum albumin at 2.5 angstrom resolution. Protein Engineering 1999, 12:439-446.
39. Cooke N. Vitamin D. Vitamin D 1998, 87-101. Academic Press, Orlando. first ed. D. Feldman, F.H. Glorieux, J.W. Pike (Eds.).
40. Williams M.H., Vanalstyne E.L., Galbraith R.M. Evidence of a novel association of unsaturated fatty-acids with GC (vitamin-D-binding protein). Biochem. Biophys. Res. Comm 1988, 153:1019-1024.
41. Ena J.M., Esteban C., Perez M.D., Uriel J., Calvo M. Fatty-acids bound to vitamin-D-binding protein (DBP) from human and bovine sera. Biochem. Int 1989, 19:1-7.
42. Dykes D., Polesky H., Cox E. Isoelectric-focusing of GC (vitamin-D binding globulin) in parentage testing. Human Genet 1981, 58:174-175.
43. Yamamoto Y., Nishimoto H., Ikemoto S. Interstitial deletion of the proximal long arm of chromosome-4 associated with father-child incompatibility within the GC-system - probable reduced gene dosage effect and partial piebald trait. Am. J. Med.Genet 1989, 32:520-523.
44. Vavrusa B., Cleve H., Constans J. A deficiency mutant of the GC-system. Human Genet 1983, 65:102-107.
45. Kawakami M., Blum C.B., Ramakrishnan R., Dell R.B., Goodman D.S. Turnover of the plasma-binding protein for vitamin-D and its metabolites in normal human-subjects. J. Clin. Endocrinol. Metab 1981, 53:1110-1116.
46. Haddad J.G., Fraser D.R., Lawson D.E.M. Vitamin-D plasma-binding protein - turnover and fate in the rabbit. J. Clin. Invest 1981, 67:1550-1560.
47. Nykjaer A., Dragun D., Walther D., Vorum H., Jacobsen C., Herz J., et al. An endocytic pathway essential for renal uptake and activation of the steroid 25-(OH) vitamin D-3. Cell 1999, 96:507-515.
48. Nykjaer A., Fyfe J.C., Kozyraki R., Leheste J.R., Jacobsen C., Nielsen M.S., et al. Cubilin dysfunction causes abnormal metabolism of the steroid hormone 25(OH) vitamin D-3. Proc. Natl. Acad. Sci. USA 2001, 98:13895-13900.
49. Leheste J.R., Melsen F., Wellner M., Jansen P., Schlichting U., Renner-Muller I., et al. Hypocalcemia and osteopathy in mice with kidney-specific megalin gene defect. Faseb J 2002, 16:247.
50. Song Y.H., Ray K., Liebhaber S.A., Cooke N.E. Vitamin D-binding protein gene transcription is regulated by the relative abundance of hepatocyte nuclear factors 1 alpha and 1 beta. J. Biol. Chem 1998, 273:28408-28418.
51. Haddad J.G., Walgate J. Radioimmunoassay of binding-protein for vitamin-D and its metabolites in human-serum - concentrations in normal subjects and patients with disorders of mineral homeostasis. J. Clin. Invest 1976, 58:1217-1222.
52. Bouillon R., Vanbaelen H., Demoor P. Measurement of vitamin D-binding protein in human-serum. J. Clin. Endocrinol. Metab 1977, 45:225-231.
53. Imawari M., Goodman D.S. Immunological and immunoassay studies of binding-protein for vitamin-D and its metabolites in human-serum. J. Clin. Invest 1977, 59:432-442.
54. Parviainen M.T., Harmoinen A., Visakorpi J.K. Immunonephelometric quantification of serum vitamin-D-binding globulin. Scandinavian J. Clin. Lab. Invest 1982, 42:571-575.
55. Bikle D.D., Gee E., Halloran B., Haddad J.G. Free 1,25-dihydroxyvitamin-D levels in serum from normal subjects, pregnant subjects, and subjects with liver-disease. J. Clin. Invest 1984, 74:1966-1971.
56. Abbas S.K., Care A.D., Vanbaelen H., Bouillon R. Plasma vitamin-D-binding protein and free 1,25-dihydroxyvitamin-D3 index in pregnant ewes and their fetuses in the last month of gestation. J. Endocrinol 1987, 115:7-12.
57. Bouillon R., Vanassche F.A., Vanbaelen H., Heyns W., Demoor P. Influence of the vitamin-D-binding protein on the serum concentration of 1,25-dihydroxyvitamin-D3 - significance of the free 1,25-dihydroxyvitamin-D3 concentration. J. Clin. Invest 1981, 67:589-596.
58. Fraser D.R., Emtage J.S. Vitamin-D in avian egg - its molecular identity and mechanism of incorporation into yolk. Biochem. J 1976, 160:671-682.
59. Cheema C., Grant B.F., Marcus R. Effects of estrogen on circulating free and total 1,25-dihydroxyvitamin-D and on the parathyroid-vitamin-D axis in postmenopausal women. J. Clin. Invest 1989, 83:537-542.
60. Harris S.S., Dawson-Hughes B. The association of oral contraceptive use with plasma 25-hydroxyvitamin D levels. J. Am. Col. Nutr 1998, 17:282-284.
61. Bouillon R., Vandoren G., Vanbaelen H., Demoor P. Immunochemical measurement of vitamin-D-binding protein in rat serum. Endocrinology 1978, 102:1709-1715.
62. Laing C.J., Fraser D.R. Changes with malnutrition in the concentration of plasma vitamin D binding protein in growing rats. Br. J. of Nutr 2002, 88:133-139.
63. Schiodt F.V., Bondesen S., Muller K., Rasmussen A., Hjortrup A., Kirkegaard P., et al. Reconstitution of the actin-scavenger system after orthotopic liver transplantation for end-stage liver disease: a prospective and longitudinal study. Liver Transplant. Surg 1999, 5:310-317.
64. Nyomba B.L., Bouillon R., Lissens W., Vanbaelen H., Demoor P. 1,25-Dihydroxyvitamin-D and vitamin-D-binding protein are both decreased in streptozotocin-diabetic rats. Endocrinology 1985, 116:2483-2488.
65. Auwerx J., Dekeyser L., Bouillon R., Demoor P. Decreased free 1,25-dihydroxycholecalciferol index in patients with the nephrotic syndrome. Nephron 1986, 42:231-235.
66. Goldschmidt-Clermont P.J., Vanbaelen H., Bouillon R., Shook T.E., Williams M.H., Nel A.E., et al. Role of group-specific component (vitamin-D binding-protein) in clearance of actin from the circulation in the rabbit. J. Clin. Invest 1988, 81:1519-1527.
67. Dueland S., Nenseter M.S., Drevon C.A. Uptake and degradation of filamentous actin and vitamin-D-binding protein in the rat. Biochem. J 1991, 274:237-241.
68. Mendel C.M. The free hormone hypothesis - a physiologically based mathematical-model. Endocrine Rev 1989, 10:232-274.
69. Chun R.F., Lauridsen A.L., Suon L., Zella L.A., Pike J.W., Modlin R.L., et al. Vitamin D-binding protein directs monocyte responses to 25-hydroxy- and 1,25-dihydroxyvitamin D. J. Clin. Endocrinol. Metab 2010, 95:3368-3376.
70. Bouillon R., Van Baelen H. The transport of vitamin D. Vitamin D Basic Res. Clin. Appl 1979, 137-143. Walter De Gruyter, Berlin. A.W. Norman, K. Schaefer, D. Von Herrath, H.G. Grigoleit, J.W. Coburn, H.F. DeLuca, E.B. Mawer, T. Suda (Eds.).
71. Pike J.W., Shevde N.K., Hollis B.W., Cooke N.E., Zella L.A. Vitamin D-binding protein influences total circulating levels of 1,25-dihydroxyvitamin D-3 but does not directly modulate the bioactive levels of the hormone in vivo. Endocrinology 2008, 149:3656-3667.
72. Christensen E.I., Willnow T.E. Essential role of megalin in renal proximal tubule for vitamin homeostasis. J. Am. Soc. Nephrol 1999, 10:2224-2236.
73. Orlando R.A., Farquhar M.G. Identification of a cell-line that expresses a cell-surface and a soluble form of the GP330 receptor-associated protein (RAP) Heymann nephritis antigenic complex. Proc. Natl. Acad. Sci. USA 1993, 90:4082-4086.
74. Christensen E.I., Nielsen S., Moestrup S.K., Borre C., Maunsbach A.B., Deheer E., et al. Segmental distribution of the endocytosis receptor GP330 in renal proximal tubules. Eur. J. Cell Biol 1995, 66:349-364.
75. Leheste J.R., Rolinski B., Vorum H., Hilpert J., Nykjaer A., Jacobsen C., et al. Megalin knockout mice as an animal model of low molecular weight proteinuria. Am. J. Pathol 1999, 155:1361-1370.
76. Christensen E.I., Moskaug J.O., Vorum H., Jacobsen C., Gundersen T.E., Nykjaer A., et al. Evidence for an essential role of megalin in transepithelial transport of retinol. J. Am. Soc. Nephrol 1999, 10:685-695.
77. Birn H., Willnow T.E., Nielsen R., Norden A.G.W., Bonsch C., Moestrup S.K., et al. Megalin is essential for renal proximal tubule reabsorption and accumulation of transcobalamin-B-12. Am. J. Physiol.-Renal Physiol 2002, 282:F408-F416.
78. Kerjaschki D., Miettinen A., Farquhar M.G. Initial events in the formation of immune deposits in passive Heymann nephritis - GP330-anti-GP330 immune-complexes form in epithelial coated pits and rapidly become attached to the glomerular-basement-membrane. J. Exp. Med 1987, 166:109-128.
79. Yamazaki H., Ullrich R., Exner M., Saito A., Orlando R.A., Kerjaschki D., et al. All four putative ligand-binding domains in megalin contain pathogenic epitopes capable of inducing passive Heymann nephritis. J. Am. Soc. Nephrol 1998, 9:1638-1644.
80. Saito A., Pietromonaco S., Loo A.K.C., Farquhar M.G. Complete cloning and sequencing of rat GP330 megalin, a distinctive member of the low-density-lipoprotein receptor gene family. Proc. Natl. Acad. Sci. USA 1994, 91:9725-9729.
81. Hjalm G., Murray E., Crumley G., Harazim W., Lundgren S., Onyango I., et al. Cloning and sequencing of human gp330, a Ca2+-binding receptor with potential intracellular signaling properties. Eur. J. Biochem 1996, 239:132-137.
82. Willnow T.E., Nykjaer A., Herz J. Lipoprotein receptors: new roles for ancient proteins. Nat. Cell Biol 1999, 1:E157-E162.
83. Kibbey R.G., Rizo J., Gierasch L.M., Anderson R.G.W. The LDL receptor clustering motif interacts with the clathrin terminal domain in a reverse turn conformation. J. Cell Biol 1998, 142:59-67.
84. Oleinikov A.V., Zhao J., Makker S.P. Cytosolic adaptor protein Dab2 is an intracellular ligand of endocytic receptor gp600/megalin. Biochem. J 2000, 347:613-621.
85. Nykjaer A., Willnow T.E. The low-density lipoprotein receptor gene family: a cellular Swiss army knife?. Trends in Cell Biol 2002, 12:273-280.
86. Willnow T.E., Hilpert J., Armstrong S.A., Rohlmann A., Hammer R.E., Burns D.K., et al. Defective forebrain development in mice lacking gp330/megalin. Proc. Natl. Acad. Sci. USA 1996, 93:8460-8464.
87. Seetharam B., Levine J.S., Ramasamy M., Alpers D.H. Purification, properties, and immunochemical localization of a receptor for intrinsic factor-cobalamin complex in the rat-kidney. J. Biol. Chem 1988, 263:4443-4449.
88. Burmeister R., Boe I.M., Nykjaer A., Jacobsen C., Moestrup S.K., Verroust P., et al. A two-receptor pathway for catabolism of Clara cell secretory protein in the kidney. J. Biol.Chem 2001, 276:13295-13301.
89. Sahali D., Mulliez N., Chatelet F., Dupuis R., Ronco P., Verroust P. Characterization of a 280-kD protein restricted to the coated pits of the renal brush-border and the epithelial-cells of the yolk-sac - teratogenic effect of the specific monoclonal-antibodies. J. Exp. Med 1988, 167:213-218.
90. Aminoff M., Carter J.E., Chadwick R.B., Johnson C., Grasbeck R., Abdelaal M.A., et al. Mutations in CUBN, encoding the intrinsic factor-vitamin B-12 receptor, cubilin, cause hereditary megaloblastic anaemia 1. Nat. Genet 1999, 21:309-313.
91. Imerslund O. Idiopathic chronic megaloblastemic anemia in children. Acta Paediatr 1960, 49:208-209.
92. Morris S.M., Tallquist M.D., Rock C.O., Cooper J.A. Dual roles for the Dab2 adaptor protein in embryonic development and kidney transport. Embo J 2002, 21:1555-1564.
93. Piwon N., Gunther W., Schwake M., Bosl M.R., Jentsch T.J. CIC-5Cl(-)-channel disruption impairs endocytosis in a mouse model for Dent's disease. Nature 2000, 408:369-373.
94. Pook M.A., Wrong O., Wooding C., Norden A.G., Feest T.G., Thakker R.V. Dent's disease, a renal Fanconi syndrome with nephrocalcinosis and kidney stones, is associated with a microdeletion involving DXS255 and maps to Xp11.22. Hum. Mol. Genet 1993, 2:2129-2134.
95. Schmidtgayk H., Grawunder C., Tschope W., Schmitt W., Ritz E., Pietsch V., et al. 25-Hydroxy-vitamin-D in nephrotic syndrome. Lancet 1977, 2:105-108.
96. Goldstein D.A., Oda Y., Kurokawa K., Massry S.G. Blood-levels of 25-hydroxyvitamin-D in nephrotic syndrome - studies in 26 patients. Ann. Intern. Med 1977, 87:664-667.
97. Barragry J.M., Carter N.D., Beer M., France M.W., Auton J.A., Boucher B.J., et al. Vitamin-D metabolism in nephrotic syndrome. Lancet 1977, 2:629-632.
98. Colston K., Williams N.J., Cleeve H.J.W. Studies on vitamin-D binding-protein in the nephrotic syndrome. Clin. Chem 1985, 31:718-721.
99. Gressner O.A., Lahme B., Gressner A.M. Gc-globulin (vitamin D binding protein) is synthesized and secreted by hepatocytes and internalized by hepatic stellate cells through Ca(2+)-dependent interaction with the megalin/gp330 receptor. Clin. Chim. Acta 2008, 390:28-37.
100. X.H. Xu, D.H. Xiong, X.G. Liu, Y. Guo, Y. Chen, J. Zhao, et al., Association analyses of vitamin D-binding protein gene with compression strength index variation in Caucasian nuclear families. Osteoporosis Int. 21 99-107.
101. Fang Y., van Meurs J.B.J., Arp P., van Leeuwen J.P.T., Hofman A., Pols H.A.P., et al. Vitamin D Binding Protein Genotype and Osteoporosis. Calcif. Tissue Int 2009, 85:85-93.
102. Pani M.A., Regulla K., Segni M., Hofmann S., Hufner M., Pasquino A.M., et al. A polymorphism within the vitamin D-binding protein gene is associated with Graves' disease but not with Hashimoto's thyroiditis. J. Clin. Endocrinol. Metab 2002, 87:2564-2567.
103. K.C. Simon, K.L. Munger, X. Yang, A. Ascherio, Polymorphisms in vitamin D metabolism related genes and risk of multiple sclerosis, Multiple Sclerosis 16 133-138.
104. T.J. Wang, F. Zhang, J.B. Richards, B. Kestenbaum, J.B. van Meurs, D. Berry, et al., Common genetic determinants of vitamin D insufficiency: a genome-wide association study, Lancet 376 180-188.
105. Bouillon R. Genetic and environmental determinants of vitamin D status. Lancet 2010, 376:148-149.
106. Sinotte M., Diorio C., Berube S., Pollak M., Brisson J. Genetic polymorphisms of the vitamin D binding protein and plasma concentrations of 25-hydroxyvitamin D in premenopausal women. Am. J. Clin. Nutr 2009, 89:634-640.
107. Janssens W., Bouillon R., Claes B., Carremans C., Lehouck A., Buysschaert I., et al. Vitamin D deficiency is highly prevalent in COPD and correlates with variants in the vitamin D-binding gene. Thorax 2010, 65:215-220.
108. Engelman C.D., Fingerlin T.E., Langefeld C.D., Hicks P.J., Rich S.S., Wagenknecht L.E., et al. Genetic and environmental determinants of 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels in Hispanic and African Americans. J. Clin. Endocrinol. Metab 2008, 93:3381-3388.
109. Fu L., Yun F., Oczak M., Wong B.Y.L., Vieth R., Cole D.E.C. Common genetic variants of the vitamin D binding protein (DBP) predict differences in response of serum 25-hydroxyvitamin D [25(OH)D] to vitamin D supplementation. Clin. Biochem 2009, 42:1174-1177.
110. Lee W.M., Galbraith R.M. Mechanisms of disease - the extracellular actin-scavenger system and actin toxicity. New Eng. J. Med 1992, 326:1335-1341.
111. Vasconcellos C.A., Lind S.E. Coordinated inhibition of actin-induced platelet-aggregation by plasma gelsolin and vitamin-D-binding protein. Blood 1993, 82:3648-3657.
112. Lind S.E., Smith D.B., Janmey P.A., Stossel T.P. Role of plasma gelsolin and the vitamin-D-binding protein in clearing actin from the circulation. J. Clin. Invest 1986, 78:736-742.
113. Herrmannsdoerfer A.J., Heeb G.T., Feustel P.J., Estes J.E., Keenan C.J., Minnear F.L., et al. Vascular clearance and organ uptake of G-actin and F-actin in the rat. Am. J. Physiol 1993, 265:G1071-G1081.
114. Haddad J.G., Hu Y.Z., Kowalski M.A., Laramore C., Ray K., Robzyk P., et al. Identification of the sterol-binding and actin-binding domains of plasma vitamin-D binding-protein (GC-globulin). Biochemistry 1992, 31:7174-7181.
115. McLeod J.F., Kowalski M.A., Haddad J.G. Interactions among serum vitamin-D binding-protein, monomeric actin, profilin, and profilactin. J. Biol. Chem 1989, 264:1260-1267.
116. Schiodt F.V. Gc-globulin in liver disease. Dan. Med. Bull 2008, 55:131-146.
117. Gressner O.A., Gao C., Siluschek M., Kim P., Gressner A.M. Inverse association between serum concentrations of actin-free vitamin D-binding protein and the histopathological extent of fibrogenic liver disease or hepatocellular carcinoma. Eur. J. Gastroenterol. Hepatol 2009, 21:990-995.
118. Schiodt F.V., Ott P., Bondesen S., Tygstrup N. Reduced serum Gc-globulin concentrations in patients with fulminant hepatic failure: association with multiple organ failure. Crit. Care Med 1997, 25:1366-1370.
119. Dahl P., Schiodt F.V., Klaer T., Ott P., Bondesen S., Tygstrup N. Serum Gc-globulin in the early course of multiple trauma. Crit. Care Med 1998, 26:285-289.
120. Lee W.M., Galbraith R.M., Watt G.H., Hughes R.D., McIntire D.D., Hoffman B.J., et al. Predicting survival in fulminant hepatic-failure using serum GC protein concentrations. Hepatology 1995, 21:101-105.
121. Schiodt F.V., Bondesen S., Petersen I., Dalhoff K., Ott P., Tygstrup N. Admission levels of serum Gc-globulin: predictive value in fulminant hepatic failure. Hepatology 1996, 23:713-718.
122. Dahl B., Schiodt F.V., Nielsen M., Kiaer T., Williams J.G., Ott P. Admission level of GC-globulin predicts outcome after multiple trauma. Injury 1999, 30:275-281.
123. DiMartino S.J., Shah A.B., Trujillo G., Kew R.R. Elastase controls the binding of the vitamin D-binding protein (Gc-globulin) to neutrophils: a potential role in the regulation of C5a co-chemotactic activity. J. Immunol 2001, 166:2688-2694.
124. Metcalf J.P., Thompson A.B., Gossman G.L., Nelson K.J., Koyama S., Rennard S.I., et al. Gc globulin functions as a cochemotaxin in the lower respiratory-tract - a potential mechanism for lung neutrophil recruitment in cigarette smokers. Am. Rev. Respira. Dis 1991, 143:844-849.
125. Kew R.R., Mollison K.W., Webster R.O. Binding of Gc globulin (vitamin-D-binding protein) to C5A or C5A DES ARG is not necessary for co-chemotactic activity. Journal of Leukocyte Biology 1995, 58:55-58.
126. Kew R.R., Fisher J.A., Webster R.O. Co-chemotactic effect of Gc-globulin (vitamin-D-binding protein) for C5A - transient conversion into an active co-chemotaxin by neutrophils. J. Immunol 1995, 155:5369-5374.
127. Binder R., Kress A., Kan G.Z., Herrmann K., Kirschfink M. Neutrophil priming by cytokines and vitamin D binding protein (Gc-globulin): impact on C5a-mediated chemotaxis, degranulation and respiratory burst. Mol. Immunol 1999, 36:885-892.
128. DiMartino S.J., Kew R.R. Initial characterization of the vitamin D binding protein (Gc-globulin) binding site on the neutrophil plasma membrane: evidence for a chondroitin sulfate proteoglycan. J. Immunol 1999, 163:2135-2142.
129. Trujillo G., Kew R.R. Platelet-derived thrombospondin-1 is necessary for the vitamin D-binding protein (Gc-globulin) to function as a chemotactic cofactor for C5a. J. Immunol 2004, 173:4130-4136.
130. Naraparaju V.R., Yamamoto N. Roles of beta-galactosidase of B-lymphocytes and sialidase of T-lymphocytes in inflammation-primed activation of macrophages. Immunol. Lett 1994, 43:143-148.
131. Yamamoto N. Structural definition of a potent macrophage activating factor derived from vitamin D-3 binding protein with adjuvant activity for antibody production. Mol. Immunol 1996, 33:1157-1164.
132. Bin Mohamad S., Nagasawa H., Uto Y., Hori H. Preparation of Gc protein-derived macrophage activating factor (GcMAF) and its structural characterization and biological activities. Anticancer Res 2002, 22:4297-4300.
133. Yamamoto N., St Claire D.A., Homma S., Ngwenya B.Z. Activation of mouse macrophages by alkylglycerols, inflammation products of cancerous tissues. Cancer Res 1988, 48:6044-6049.
134. Koga Y., Naraparaju V.R., Yamamoto N. Antitumor effect of vitamin D-binding protein-derived macrophage activating factor on Ehrlich ascites tumor-bearing mice. Proc. Soc. Exp. Biol. Med 1999, 220:20-26.
135. Yamamoto N., Naraparaju V.R., Neil R.N., Suyama H., Nakazato H. Therapeutic efficiency of vitamin D3-binding protein-derived macrophage activating factor for prostate, breast, and colon cancer. Proc. Am. Assoc. Cancer Res 1997, 38.
136. Yamamoto N., Urade M. Therapeutic efficacy of Gc protein derived macrophage activating factor for adenocarcinoma. Proc. Am. Assoc. Cancer Res 2002, 43.
137. Kisker O., Onizuka S., Becker C.M., Fannon M., Flynn E., D'Amato R., et al. Vitamin D binding protein-macrophage activating factor (DBP-maf) inhibits angiogenesis and tumor growth in mice. Neoplasia 2003, 5:32-40.
138. Yamamoto N., Suyama H., Nakazato H., Koga Y. Immunotherapy of metastatic colorectal cancer with vitamin D-binding protein-derived macrophage-activating factor, GcMAF. Cancer Immunology Immunotherapy 2008, 57:1007-1016.
139. Yamamoto N., Suyama H., Ushijima N. Immunotherapy of metastatic breast cancer patients with vitamin D-binding protein-derived macrophage activating factor (GcMAF). International J. Cancer 2008, 122:461-467.
140. Bogani F., McConnell E., Joshi L., Chang Y., Ghirlanda G. A designed glycoprotein analogue of Gc-MAF exhibits native-like phagocytic activity. Journal of the Am. Chem. Soc 2006, 128:7142-7143.
141. Yamamoto N., Ushijima N., Koga Y. Immunotherapy of HIV-infected patients with Gc protein-derived macrophage activating factor (GcMAF). J. Med. Virol 2009, 81:16-26.
142. Swamy N., Ghosh S., Schneider G.B., Ray R. Baculovirus-expressed vitamin D-binding protein-macrophage activating factor (DBP-maf) activates osteoclasts and binding of 25-hydroxyvitamin D-3 does not influence this activity. J. Cell Biochem 2001, 81:535-546.
143. Schneider G.B., Benis K.A., Flay N.W., Ireland R.A., Popoff S.N. Effects of vitamin-D-binding protein-macrophage activating factor (DBP-MAF) infusion on bone-resorption in 2 osteopetrotic mutations. Bone 1995, 16:657-662.
144. Yamamoto N., Naraparaju V.R. A defect in beta-galactosidase of B lymphocytes in the osteopetrotic (op/op) mouse. Immunol. Lett 1996, 50:35-40.
145. Datta H.K., Cook D.B., Kanan R.M., Gennery A.R., Cant A.J. Evidence for continuous basal generation of Gc-MAF: absence in infantile osteopetrosis and restoration after bone marrow transplant. Blood 1999, 93:4026-4027.
146. Kanda S., Mochizuki Y., Miyata Y., Kanetake H., Yamamoto N. Effects of vitamin D-3-binding protein-derived macrophage activating factor (GcMAF) on angiogenesis. J. Natl. Cancer Inst 2002, 94:1311-1319.
147. Odgren P.R., Popoff S.N., Safadi F.F., MacKay C.A., Mason-Savas A., Seifert M.F., et al. The toothless osteopetrotic rat has a normal vitamin D-binding protein-macrophage activating factor (DBP-MAF) cascade and chondrodysplasia resistant to treatments with colony stimulating factor-1 (CSF-1) and/or DBP-MAF. Bone 1999, 25:175-181.
148. White P., Liebhaber S.A., Cooke N.E. 129X1/SvJ mouse strain has a novel defect in inflammatory cell recruitment. J. Immunol 2002, 168:869-874.